ÂÜÀòÂÒÂ×

Andrew Allen serves as a Member of the Board of Directors for both Adaptimmune and Verge Genomics, and holds the position of Chairperson of the Board at Peptone. In addition, Andrew Allen is the President, CEO, and Co-Founder of Gritstone bio, and a Board Member at TCR² Therapeutics Inc. Academic qualifications include education from the University of Oxford and Imperial College London.